These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 16480713

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Steroids modulate N-methyl-D-aspartate-stimulated [3H] dopamine release from rat striatum via sigma receptors.
    Nuwayhid SJ, Werling LL.
    J Pharmacol Exp Ther; 2003 Sep; 306(3):934-40. PubMed ID: 12750428
    [Abstract] [Full Text] [Related]

  • 3. Sigma1 receptor agonist-mediated regulation of N-methyl-D-aspartate-stimulated [3H]dopamine release is dependent upon protein kinase C.
    Nuwayhid SJ, Werling LL.
    J Pharmacol Exp Ther; 2003 Jan; 304(1):364-9. PubMed ID: 12490613
    [Abstract] [Full Text] [Related]

  • 4. Release of [3H]dopamine from guinea pig striatal slices is modulated by sigma1 receptor agonists.
    Gonzalez GM, Werling LL.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):455-61. PubMed ID: 9349631
    [Abstract] [Full Text] [Related]

  • 5. Regulation of [3H]dopamine release from rat striatal slices by sigma receptor ligands.
    Gonzalez-Alvear GM, Werling LL.
    J Pharmacol Exp Ther; 1994 Oct; 271(1):212-9. PubMed ID: 7965717
    [Abstract] [Full Text] [Related]

  • 6. Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists.
    Izenwasser S, Thompson-Montgomery D, Deben SE, Chowdhury IN, Werling LL.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):189-96. PubMed ID: 9652359
    [Abstract] [Full Text] [Related]

  • 7. Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C.
    Derbez AE, Mody RM, Werling LL.
    J Pharmacol Exp Ther; 2002 Apr 10; 301(1):306-14. PubMed ID: 11907188
    [Abstract] [Full Text] [Related]

  • 8. Modulation of amphetamine-stimulated [3H]dopamine release from rat pheochromocytoma (PC12) cells by sigma type 2 receptors.
    Weatherspoon JK, Werling LL.
    J Pharmacol Exp Ther; 1999 Apr 10; 289(1):278-84. PubMed ID: 10087015
    [Abstract] [Full Text] [Related]

  • 9. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
    Gronier B, Debonnel G.
    Eur J Pharmacol; 1999 Mar 05; 368(2-3):183-96. PubMed ID: 10193654
    [Abstract] [Full Text] [Related]

  • 10. sigma1 Receptors in rat striatum regulate NMDA-stimulated [3H]dopamine release via a presynaptic mechanism.
    Gonzalez-Alvear GM, Werling LL.
    Eur J Pharmacol; 1995 Dec 29; 294(2-3):713-9. PubMed ID: 8750737
    [Abstract] [Full Text] [Related]

  • 11. Trishomocubanes: novel sigma-receptor ligands modulate amphetamine-stimulated [3H]dopamine release.
    Liu X, Nuwayhid S, Christie MJ, Kassiou M, Werling LL.
    Eur J Pharmacol; 2001 Jun 22; 422(1-3):39-45. PubMed ID: 11430911
    [Abstract] [Full Text] [Related]

  • 12. Modulation of [3H]Dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor.
    Ault DT, Radeff JM, Werling LL.
    J Pharmacol Exp Ther; 1998 Feb 22; 284(2):553-60. PubMed ID: 9454797
    [Abstract] [Full Text] [Related]

  • 13. Regulation of NMDA-induced [3H]dopamine release from rat hippocampal slices through sigma-1 binding sites.
    Chaki S, Okuyama S, Ogawa S, Tomisawa K.
    Neurochem Int; 1998 Jul 22; 33(1):29-34. PubMed ID: 9694039
    [Abstract] [Full Text] [Related]

  • 14. Regulation of [3H]norepinephrine release from guinea pig hippocampus by sigma2 receptors.
    Weatherspoon JK, Gonzalez-Alvear GM, Werling LL.
    Eur J Pharmacol; 1997 May 20; 326(2-3):133-8. PubMed ID: 9196265
    [Abstract] [Full Text] [Related]

  • 15. Modulation of the neuronal response to N-methyl-D-aspartate by selective sigma2 ligands.
    Couture S, Debonnel G.
    Synapse; 1998 May 20; 29(1):62-71. PubMed ID: 9552175
    [Abstract] [Full Text] [Related]

  • 16. Protein kinase C-dependent potentiation of intracellular calcium influx by sigma1 receptor agonists in rat hippocampal neurons.
    Monnet FP, Morin-Surun MP, Leger J, Combettes L.
    J Pharmacol Exp Ther; 2003 Nov 20; 307(2):705-12. PubMed ID: 12975497
    [Abstract] [Full Text] [Related]

  • 17. A selective sigma-2 receptor ligand antagonizes cocaine-induced hyperlocomotion in mice.
    Lever JR, Miller DK, Green CL, Fergason-Cantrell EA, Watkinson LD, Carmack TL, Fan KH, Lever SZ.
    Synapse; 2014 Feb 20; 68(2):73-84. PubMed ID: 24123353
    [Abstract] [Full Text] [Related]

  • 18. Comparison of dopamine uptake and release in vitro in sheep and rat striatum.
    Jacocks HM, Izenwasser S, Werling LL, Cox BM.
    Life Sci; 1991 Feb 20; 49(7):481-8. PubMed ID: 1830633
    [Abstract] [Full Text] [Related]

  • 19. Modulation of striatal dopamine release in vitro by agonists of the glycineB site of NMDA receptors; interaction with antipsychotics.
    Bennett S, Gronier B.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):52-9. PubMed ID: 16307739
    [Abstract] [Full Text] [Related]

  • 20. Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.
    Hiranita T, Soto PL, Kohut SJ, Kopajtic T, Cao J, Newman AH, Tanda G, Katz JL.
    J Pharmacol Exp Ther; 2011 Nov 19; 339(2):662-77. PubMed ID: 21859929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.